Mesa LaboratoriesMLAB
About: Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Employees: 736
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
67% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 18
42% more capital invested
Capital invested by funds: $446M [Q2] → $635M (+$189M) [Q3]
6% more funds holding
Funds holding: 154 [Q2] → 164 (+10) [Q3]
8% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 51
4.69% less ownership
Funds ownership: 95.29% [Q2] → 90.6% (-4.69%) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for MLAB.
Financial journalist opinion
